SCM
Soleus Capital Management’s Nurix Therapeutics NRIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.6M | Hold |
2,422,833
| – | – | 1.83% | 15 |
|
|
2025
Q1 | $28.8M | Buy |
2,422,833
+320,000
| +15% | +$3.8M | 2.07% | 12 |
|
|
2024
Q4 | $39.6M | Buy |
2,102,833
+1,036,999
| +97% | +$19.5M | 2.49% | 11 |
|
|
2024
Q3 | $23.9M | Sell |
1,065,834
-990,082
| -48% | -$22.2M | 1.85% | 17 |
|
|
2024
Q2 | $42.9M | Buy |
2,055,916
+940,916
| +84% | +$19.6M | 3.78% | 4 |
|
|
2024
Q1 | $16.4M | Buy |
1,115,000
+972,000
| +680% | +$14.3M | 1.22% | 23 |
|
|
2023
Q4 | $1.48M | Sell |
143,000
-671,000
| -82% | -$6.92M | 0.16% | 59 |
|
|
2023
Q3 | $6.4M | Buy |
+814,000
| New | +$6.4M | 0.59% | 45 |
|
|
2022
Q4 | – | Sell |
-504,144
| Closed | -$6.57M | – | 84 |
|
|
2022
Q3 | $6.57M | Sell |
504,144
-490,348
| -49% | -$6.39M | 0.89% | 33 |
|
|
2022
Q2 | $12.6M | Sell |
994,492
-17,146
| -2% | -$217K | 1.97% | 16 |
|
|
2022
Q1 | $14.2M | Buy |
1,011,638
+268,400
| +36% | +$3.76M | 1.83% | 19 |
|
|
2021
Q4 | $21.5M | Buy |
743,238
+479,338
| +182% | +$13.9M | 2.15% | 11 |
|
|
2021
Q3 | $7.91M | Buy |
+263,900
| New | +$7.91M | 1.23% | 26 |
|